Cargando…
Discontinuation of adjuvant endocrine therapy and impact on quality of life and functional status in older patients with breast cancer
PURPOSE: Side effects are the main reason for discontinuation of adjuvant endocrine therapy in older adults. The aim of this study was to examine geriatric predictors of treatment discontinuation of adjuvant endocrine therapy within the first 2 years after initiation, and to study the association be...
Autores principales: | Lemij, Annelieke A., de Glas, Nienke A., Derks, Marloes G. M., Bastiaannet, Esther, Merkus, Jos W. S., Lans, Titia E., van der Pol, Carmen C., van Dalen, Thijs, Vulink, Annelie J. E., van Gerven, Leander, Guicherit, Onno R., Linthorst-Niers, Eugenie M. H., van den Bos, Frederiek, Kroep, Judith R., Liefers, Gerrit Jan, Portielje, Johanneke E. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114046/ https://www.ncbi.nlm.nih.gov/pubmed/35441273 http://dx.doi.org/10.1007/s10549-022-06583-7 |
Ejemplares similares
-
Physical Function and Physical Activity in Older Breast Cancer Survivors: 5-Year Follow-Up from the Climb Every Mountain Study
por: Lemij, Annelieke A, et al.
Publicado: (2023) -
Differences in treatment and survival of older patients with operable breast cancer between the United Kingdom and the Netherlands – A comparison of two national prospective longitudinal multi-centre cohort studies
por: van der Plas-Krijgsman, Willeke G., et al.
Publicado: (2022) -
Time Trends in Treatment Strategies and Survival of Older versus Younger Patients with Synchronous Metastasised Melanoma—A Population-Based Study in the Netherlands Cancer Registry
por: van der Ziel, Daisy, et al.
Publicado: (2022) -
Efficacy and Adverse Events of Immunotherapy with Checkpoint Inhibitors in Older Patients with Cancer
por: van Holstein, Yara, et al.
Publicado: (2019) -
The impact of geriatric characteristics and comorbidities on distant metastases and other cause mortality in older women with non-metastatic breast cancer treated with primary endocrine therapy
por: Waaijer, M. E.C., et al.
Publicado: (2023)